Literature DB >> 9730957

Induction of Mn SOD in human monocytes without inflammatory cytokine production by a mutant endotoxin.

L Tian1, J E White, H Y Lin, V S Haran, J Sacco, G Chikkappa, F B Davis, P J Davis, M F Tsan.   

Abstract

Endotoxin selectively induces monocyte Mn superoxide dismutase (SOD) without affecting levels of Cu,Zn SOD, catalase, or glutathione peroxidase. However, little is known about the structure-activity relationship and the mechanism by which endotoxin induces Mn SOD. In this study we demonstrated that a mutant Escherichia coli endotoxin lacking myristoyl fatty acid at the 3' R-3-hydroxymyristate position of the lipid A moiety retained its full capacity to coagulate Limulus amoebocyte lysate compared with the wild-type E. coli endotoxin and markedly stimulated the activation of human monocyte nuclear factor-kappaB and the induction of Mn SOD mRNA and enzyme activity. However, in contrast to the wild-type endotoxin, it failed to induce significant production of tumor necrosis factor-alpha and macrophage inflammatory protein-1alpha by monocytes and did not induce the phosphorylation and nuclear translocation of mitogen-activated protein kinase. These results suggest that 1) lipid A myristoyl fatty acid, although it is important for the induction of inflammatory cytokine production by human monocytes, is not necessary for the induction of Mn SOD, 2) endotoxin-mediated induction of Mn SOD and inflammatory cytokines are regulated, at least in part, through different signal transduction pathways, and 3) failure of the mutant endotoxin to induce tumor necrosis factor-alpha production is, at least in part, due to its inability to activate mitogen-activated protein kinase.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9730957     DOI: 10.1152/ajpcell.1998.275.3.C740

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  8 in total

1.  In vitro cloning of complex mixtures of DNA on microbeads: physical separation of differentially expressed cDNAs.

Authors:  S Brenner; S R Williams; E H Vermaas; T Storck; K Moon; C McCollum; J I Mao; S Luo; J J Kirchner; S Eletr; R B DuBridge; T Burcham; G Albrecht
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-15       Impact factor: 11.205

2.  Comparison of lipopolysaccharide-binding functions of CD14 and MD-2.

Authors:  Jun Koraha; Naoko Tsuneyoshi; Masao Kimoto; Jean-Francois Gauchat; Hiroshi Nakatake; Kenji Fukudome
Journal:  Clin Diagn Lab Immunol       Date:  2005-11

Review 3.  Toll-like receptor 4 in CNS pathologies.

Authors:  Madison M Buchanan; Mark Hutchinson; Linda R Watkins; Hang Yin
Journal:  J Neurochem       Date:  2010-04-06       Impact factor: 5.372

4.  The lipid A region of lipopolysaccharides from Rhizobiaceae activates bone marrow granulocytes from lipopolysaccharide-hyporesponsive C3H/HeJ and C57BL/10ScCr mice.

Authors:  T Pedron; R Girard; B Jeyaretnam; R W Carlson; R Chaby
Journal:  Immunology       Date:  2000-10       Impact factor: 7.397

Review 5.  Association of Nrf2 with airway pathogenesis: lessons learned from genetic mouse models.

Authors:  Hye-Youn Cho; Steven R Kleeberger
Journal:  Arch Toxicol       Date:  2015-07-21       Impact factor: 5.153

6.  Fetal calf serum heat inactivation and lipopolysaccharide contamination influence the human T lymphoblast proteome and phosphoproteome.

Authors:  Hazir Rahman; Muhammad Qasim; Frank C Schultze; Michael Oellerich; Abdul R Asif
Journal:  Proteome Sci       Date:  2011-11-15       Impact factor: 2.480

7.  Lipopolysaccharide regulated protein expression is only partly impaired in monocytes from patients with type I diabetes.

Authors:  Gabriele Wehrwein; Markus Neumeier; Andreas Schäffler; Andrea Kopp; Johanna Weigert; Sabine Abke; Jürgen Schölmerich; Christa Buechler
Journal:  Cardiovasc Diabetol       Date:  2006-03-27       Impact factor: 9.951

8.  Divergent signalling pathways regulate lipopolysaccharide-induced eRNA expression in human monocytic THP1 cells.

Authors:  James A Heward; Benoit T Roux; Mark A Lindsay
Journal:  FEBS Lett       Date:  2014-12-29       Impact factor: 4.124

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.